Catalog No.
Product Name
Application
Product Information
Product Citation
- Eltrombopag is an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia.
-
Thrombopoietin(TPO) receptor agonist
Avatrombopag is a novel orally-active thrombopoietin (TPO) receptor agonist. -
c-mpl (TpoR) receptor agonist
Eltrombopag olamine is a new, orally active thrombopoietin-receptor (c-mpl) agonist that stimulates thrombopoiesis. -
TPO agonist
TPO agonist 1 can increase production of platelets by stimulating the TPO receptor in people with chronic ITP. -
thrombopoietin (TPO) receptor agonist
Lusutrombopag, also known as S-888711, is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery.
